A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
Clinical trial NCT00000663 · COMPLETED
Trial details
- NCT number
- NCT00000663
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.